The Massachusetts General Hospital Guide to Depression
New Treatment Insights and Options
Samenvatting
Major Depressive Disorder (MDD) is one of the most prevalent psychiatric disorders, with a lifetime prevalence rate of roughly 20%. MDD is a leading cause of disability and premature death worldwide, leads to greater impairment in work functioning than other chronic medical conditions, and has an estimated annual cost of $210 billion in the US.
The proposed text is designed for mental health professionals and will present state-of-the-art treatment options that are used in the Depression Clinical and Research Program (DCRP) at the Massachusetts General Hospital. The text provides different treatment options so that providers can ‘think outside the box’ of conventional interventions. The introductory sections discuss general themes about diagnosing and treating depression. The major body of the book, however, consists of chapters organized under the topics of new medication, new psychotherapy, alternative treatments, and consideration of specific populations and how to modify interventions to best treat these patients. Each chapter begins with a case vignette to illustrate key characteristics of the disorder process or treatment and reviews the history, research support, and new advances of these topics. In addition, the chapters include a description of how to apply this topic in treatment and frequently asked questions and answers.
This book will be a unique contribution to the field. Existing guides focus on individual treatments of Depression, or include brief descriptions of interventions as a whole. The DCRP has consistently been a forerunner of clinical treatments for depression and often treats challenging cases of this disorder. This book will provide a practical and useful resource with wide applicability.
Specificaties
Inhoudsopgave
<p>Jerrold Rosenbaum </p>
<p> </p>
<p>Foreword-Introduction and Historical Perspective </p>
<p>Maurizio Fava</p>
<p> </p>
Preface – Benjamin G. Shapero, David Mischoulon, Cristina Cusin<p></p>
<p> </p>
<p>Part 1 Severe and Comorbid Conditions</p>
<p> </p>
<p>Chapter 1</p>
<p>Treatment-Resistant Depression</p>
Cristina Cusin and Stefan Peyda <p></p>
<p> </p>
<p>Chapter 2</p>
<p>Co-Occurring MDD and Problematic Alcohol Use</p>
<p>Paola Pedrelli and Kate H. Bentley</p>
<p> </p>
<p></p>
<p>Part 2 Special Population Considerations </p>
<p> </p>
<p>Chapter 3</p>
<p>Depression and Chronic Medical Illness: New Treatment Approaches</p>
<p>Trina E. Chang and Sean D. Boyden</p>
<p></p>
<p>Chapter 4</p>
<p>Culture and Depression: Clinical Considerations for Racial and Ethnic Minorities</p>
<p>Nhi-Ha Trinh and Taquesha Dean</p>
<p> </p>
<p>Chapter 5</p>
Early Onset of Depression During Childhood and Adolescence<p></p>
<p>Benjamin G. Shapero and Erica Mazzone</p>
<p> </p>
<p>Chapter 6</p>
<p>Cross-Cultural Approaches to Mental Health Challenges Among Students</p>
<p>Xiaoqiao Zhang, Tat Shing Yeung, Yi Yang, Rohit M. Chandra, Cindy H. Liu, Dana Wang, Sukhmani K. Bal, Yun Zhu, Rebecca Nika W. Tsai, Zhenyu Zhang, Lusha Liu and Justin A. Chen</p>
<p> </p>
<p>Chapter 7</p>
<p>Depression After Traumatic Brain Injury</p>
<p>Lauren B. Fisher, Garrett Thomas, Ryan A. Mace, and Ross Zafonte</p>
<p> </p>
<p></p>
<p>Part 3 Medication Approaches </p>
<p> </p>
<p>Chapter 8</p>
<p>Personalized Medicine </p>
<p>Simmie L. Foster, Samuel R. Petrie, David Mischoulon, and Maurizio Fava</p>
<p></p>
<p>Chapter 9</p>
<p>Depression, Antidepressants, and Sexual Functioning</p>
<p>Christina M. Dording and Sean D. Boyden</p>
<p> </p>
<p>Chapter 10</p>
Ketamine as a Rapid Antidepressant<p></p>
<p>Cristina Cusin</p>
<p> </p>
<p>Chapter 11</p>
<p>Neuroactive Steroids and Depression</p>
<p>Karen K. Miller</p>
<p></p>
<p> </p>
<p>Part 4 Psychotherapy Approaches</p>
<p> </p>
<p>Chapter 12</p>
<p>Unified Protocol for Treatment of Depression</p>
<p>Kate H. Bentley, Laren R. Conklin, James F. Boswell, Benjamin G. Shapero, and Olenka S. Olesnycky</p>
<p> </p>
<p>Chapter 13</p>
<p>Mindfulness Based Cognitive Therapy</p>
<p>Benjamin G. Shapero, Jonathan Greenberg, Paola Pedrelli, Gaelle Desbordes, and Sara W. Lazar</p>
<p> </p>
Chapter 14<p></p>
<p>The Role of Technology in the Treatment of Depression</p>
<p>Paola Pedrelli, Kate H. Bentley, Esther Howe, and Benjamin G. Shapero</p>
<p> </p>
<p> </p>
<p>Part 5 Alternative Treatment Approaches</p>
<p></p>
<p>Chapter 15</p>
<p>Supplements and Natural Remedies for Depression</p>
<p>David Mischoulon and Nadia Iovieno</p>
<p> </p>
<p>Chapter 16</p>
The Effects of Tai Chi and Qigong on Anxiety and Depression<p></p>
<p>Albert Yeung, Benjamin Campbell, and Jessie S. M. Chan</p>
<p> </p>
<p>Chapter 17</p>
<p>Yoga as a Treatment for Depression</p>
<p>Maren Nyer, Regina Roberg, Maya Nauphal, and Chris Streeter</p>
<p> </p>
<p>Chapter 18</p>
<p>Photobiomodulation</p>
Marco Antonio Caldieraro and Paolo Cassano<br>